Related references
Note: Only part of the references are listed.Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons
Reinhard Roessler et al.
STEM CELL REPORTS (2014)
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging
Justine D. Miller et al.
CELL STEM CELL (2013)
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Guang-Hui Liu et al.
NATURE (2012)
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
Oliver Cooper et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Ha Nam Nguyen et al.
CELL STEM CELL (2011)
Epigenetic memory in induced pluripotent stem cells
K. Kim et al.
NATURE (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
Bin Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2009)
Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner
Anna L. M. Ferri et al.
DEVELOPMENT (2007)
A genomic pathway approach to a complex disease: Axon guidance and parkinson disease
Timothy G. Lesnick et al.
PLOS GENETICS (2007)
Pitx3 is required for development of substantia nigra dopaminergic neurons
I Nunes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
In vitro differentiation of transplantable neural precursors from human embryonic stem cells
SC Zhang et al.
NATURE BIOTECHNOLOGY (2001)